FCG
REGN icon

Fielder Capital Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Fielder Capital Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385K Buy
498
+47
+10% +$36K 0.08% 161
2025
Q4 		$348K Buy
451
+67
+17% +$45.5K 0.07% 162
2025
Q3 		$216K Buy
+384
New +$217K 0.05% 239
2024
Q4 		– Sell
-263
Closed -$276K – 228
2024
Q3 		$276K Sell
263
-1
-0.4% -$1.11K 0.09% 144
2024
Q2 		$277K Buy
264
+4
+2% +$3.88K 0.11% 130
2024
Q1 		$250K Sell
260
-4
-2% -$3.8K 0.11% 128
2023
Q4 		$232K Buy
+264
New +$217K 0.14% 119

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fielder Capital Group's REGN Position: Q1 2026 in Review

Fielder Capital Group increased its Regeneron Pharmaceuticals (REGN) stake by 10% in Q1 2026, buying an estimated $36K and bringing the position to 498 shares worth $385K. The position accounts for 0.08% of the portfolio, ranked #161.

Fielder Capital Group first reported a position in REGN in Q4 2023 and has held it in 7 quarters since. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Fielder Capital Group held 498 shares of Regeneron Pharmaceuticals worth $385K as of Q1 2026.
  • Fielder Capital Group bought 47 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $36K.
  • Regeneron Pharmaceuticals made up 0.08% of Fielder Capital Group's portfolio in Q1 2026, its #161 holding.
  • Fielder Capital Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Fielder Capital Group's 13F filing for Q1 2026, filed 12 May 2026.